Hepatosan^® (Capsules) Instructions for Use

Marketing Authorization Holder

Medminiprom, CJSC (Russia)

ATC Code

A05BA (Drugs for the treatment of liver diseases)

Dosage Form

Hepatosan®

Capsules 200 mg: 10, 20, or 30 pcs.

Dosage Form, Packaging, and Composition

Capsules are hard gelatin, size 0, with a yellow cap and body; the capsule contents are a light brown powder with a specific odor.

Composition of the gelatin capsule: titanium dioxide – 1.333%, quinoline yellow dye – 0.9197%, sunset yellow dye – 0.0044%), gelatin – up to 100%.

10 pcs. – plastic containers (1) – cardboard packs.
20 pcs. – plastic containers (1) – cardboard packs.
30 pcs. – plastic containers (1) – cardboard packs.

Clinical-Pharmacological Group

Hepatoprotective agent

Pharmacotherapeutic Group

Hepatoprotective agent

Pharmacological Action

It enhances the detoxification and protein-synthesizing functions of the liver, improves the metabolic capacity of liver cells, and promotes the sorption and elimination of toxins.

The mechanism of action has two phases: an intestinal phase, in which detoxification occurs due to the sorption of toxic products in the intestine, and a metabolic (hepatoprotective) phase, in which the biological components of the drug help restore the functional activity of the liver.

Indications

Liver cirrhosis of various etiologies; chronic hepatopathies (hepatitis, hepatosis); acute and chronic liver failure; drug-induced and alcoholic liver damage; poisonings; digestive disorders (as part of complex therapy).

ICD codes

Dosage Regimen

Take orally 15-20 minutes before meals with a small amount of water.

Swallow the capsules whole; do not chew.

For adults, the standard dosage is 2 capsules taken twice daily.

The maximum single dose is 2 capsules; the maximum daily dose is 4 capsules.

For chronic conditions (hepatitis, cirrhosis, hepatosis), the typical treatment course is 20-30 days.

Repeat courses may be prescribed by a physician after a 2-3 month interval.

For acute conditions and poisonings, the duration of therapy is determined individually based on severity.

Adjust the dosage and duration based on the clinical course and severity of the disease as directed by a physician.

Adverse Reactions

Allergic reactions are possible.

Contraindications

Individual intolerance.

Use in Hepatic Impairment

Used for liver function impairments.

Storage Conditions

Store at 2°C (36°F) to 15°C (59°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.